2 commercial payer policies list 88237. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
2 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 88237 |
|---|---|---|
| Tumor Chemosensitivity Assays | Mar 29, 2023 | Covered |
| Policy | Effective | Status of 88237 |
|---|---|---|
| Concert Genetic Testing Oncology: Hematologic Malignancy | Not recorded | Referenced |